CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Net Sales	$ 61,302,801	$ 63,388,617
Cost of Sales	58,463,859	64,973,157
Gross Profit (Loss)	2,838,942	(1,584,540)
Selling and Marketing	9,050,033	1,004,584
General and Administrative	20,997,948	22,077,720
Settlement Expense, net of Reimbursement	430,000	1,030,000
Research and Product Development	6,886,251	5,642,317
Research and Development - Licenses Acquired (Related Party)	0	1,100,000
Operating Loss	(34,525,290)	(32,439,161)
Other Income (Expense)
Realized Gain (Loss) on Investments	30,182	(222,338)
Interest Income	367,077	535,641
Total Other Income	397,259	313,303
Net Loss	$ (34,128,031)	$ (32,125,858)
Basic and Diluted Net Loss per Share (in dollars per share)	$ (0.56)	$ (0.61)
Basic and Diluted Weighted Average Shares Outstanding (in shares)	60,918,544	52,824,486